Home 2024

Archives

Figure 1: Risk and protective factors according to Substance Abuse and Mental Health Services Administration (2021)

Risk factors for cannabis use in young people

With cannabis use among young people on the rise, Ronan Fleury, Prof Bobby Smyth and Prof Mary Cannon. discuss the mental and physical impacts and the importance of understanding the risk factors.
Figure 1: Scientific innovations in ECS research and drug discovery that will strongly impact the future discovery of improved and tailor-made CB2R medicines.

CB₂R ligands to treat inflammatory diseases

Researchers discuss how scientific innovations might influence the discovery of future tailor-made CB2R-based anti-inflammatory treatments.
Marijuana buds sitting next to prescription medicine bottle

Exploring the effects of medical cannabis for chronic pain

Dr Simon Erridge of Sapphire Medical Clinics discusses the therapeutic effects of medical cannabis for chronic pain, affecting 15.5 million people in England and why more evidence is needed to support greater patient access.
Inflammation concept, inflamed human tissues 3d rendering.

CB2R agonists in the clinics: A treasure chest for treating inflammatory diseases

Researchers give an update on clinical trials with CB2R agonists and their potential for the treatment of inflammatory diseases.
Detail of cannabis flower marijuana bud with visible trichomes and ready for harvest bluedream

Analysing the effects of using cannabis on youth mental health

Mary Cannon, Professor of Psychiatric Epidemiology and Youth Mental Health at RCSI University of Medicine and Health Sciences, investigates the effects of using cannabis on young people’s mental health.
Densely packed cannabis plants under LED lights at large scale industrial growing operation.

Visualizing the anti-inflammatory cannabinoid Type-2 receptor

Medicinal chemists describe how small molecule probes allow for the detection of CB2R, and thereby enable the discovery of novel anti-inflammatory treatments.
cannais plants

Challenges bringing CB₂R medicine to bedside

Drug hunters explain how to overcome pitfalls on the way to CB2R medicine and therapeutics.
cannabis to treat diseases

Is CB₂R a hidden treasure trove for treating inflammatory diseases?

Expert scientists working on endocannabinoid system (ECS) trials explain how CB₂R can be used to treat inflammatory diseases.

Follow Us

Advertisements

Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd